Insider Ledger
PAHC insider buying and SEC filings, explained
Phibro Animal Health Corp. · CIK 1069899
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq
- Industry (SIC)
- Pharmaceutical Preparations
- State of incorporation
- DE
- Fiscal year end
- Jun 30
- Former names
- PHILIPP BROTHERS CHEMICALS INC
Insider activity in the last 12 months
Bought
$318K
Insiders who bought
1
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$28.1M
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| May 29, 2026 | Purchase (code P) | E. Thomas Corcoran (Director) bought 10,000 shares at about $31.77 ($318K), reported as a purchase (code P). Holdings up 32% to 41,459 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 2, 2026 |
| May 5–7, 2026 | Planned (10b5-1) | Jack Bendheim (CEO and Director) sold 18,608 shares indirectly between May 5 and May 7 at about $54.62 ($1.0M), marked as a 10b5-1 plan trade. Indirect holdings down 25% to 56,152 shares. Filed jointly with 1 other reporting owner. | SEC filing Filed May 7, 2026 |
| Apr 28–30, 2026 | Planned (10b5-1) | Jack Bendheim (CEO and Director) sold 21,120 shares indirectly between Apr 28 and Apr 30 at about $53.86 ($1.1M), marked as a 10b5-1 plan trade. Indirect holdings down 22% to 74,760 shares. Filed jointly with 1 other reporting owner. | SEC filing Filed Apr 30, 2026 |
| Apr 21–23, 2026 | Planned (10b5-1) | Jack Bendheim (CEO and Director) sold 21,120 shares indirectly between Apr 21 and Apr 23 at about $54.79 ($1.2M), marked as a 10b5-1 plan trade. Indirect holdings down 18% to 95,880 shares. Filed jointly with 1 other reporting owner. | SEC filing Filed Apr 23, 2026 |
| Apr 14–16, 2026 | Planned (10b5-1) | Jack Bendheim (CEO and Director) sold 21,120 shares indirectly between Apr 14 and Apr 16 at about $56.89 ($1.2M), marked as a 10b5-1 plan trade. Indirect holdings down 15% to 117,000 shares. Filed jointly with 1 other reporting owner. | SEC filing Filed Apr 16, 2026 |
| Mar 30–31, 2026 | Planned (10b5-1) | Jack Bendheim (CEO and Director) sold 14,080 shares indirectly between Mar 30 and Mar 31 at about $53.75 ($757K), marked as a 10b5-1 plan trade. Indirect holdings down 27% to 38,120 shares. Filed jointly with 1 other reporting owner. | SEC filing Filed Mar 31, 2026 |
| Mar 24–26, 2026 | Planned (10b5-1) | Jack Bendheim (CEO and Director) sold 21,120 shares indirectly between Mar 24 and Mar 26 at about $55.21 ($1.2M), marked as a 10b5-1 plan trade. Indirect holdings down 29% to 52,200 shares. Filed jointly with 1 other reporting owner. | SEC filing Filed Mar 26, 2026 |
| Mar 17–19, 2026 | Planned (10b5-1) | Jack Bendheim (CEO and Director) sold 22,880 shares indirectly between Mar 17 and Mar 19 at about $52.40 ($1.2M), marked as a 10b5-1 plan trade. Indirect holdings down 24% to 73,320 shares. Filed jointly with 1 other reporting owner. | SEC filing Filed Mar 19, 2026 |
| Mar 13, 2026 | Planned (10b5-1) | Jack Bendheim (CEO and Director) sold 5,280 shares indirectly at about $48.91 ($258K), marked as a 10b5-1 plan trade. Indirect holdings down 5% to 96,200 shares. Filed jointly with 1 other reporting owner. | SEC filing Filed Mar 16, 2026 |
| Feb 24–26, 2026 | Planned (10b5-1) | Jack Bendheim (CEO and Director) sold 21,120 shares indirectly between Feb 24 and Feb 26 at about $52.27 ($1.1M), marked as a 10b5-1 plan trade. Indirect holdings down 93% to 1,480 shares. Filed jointly with 1 other reporting owner. | SEC filing Filed Feb 26, 2026 |
| Feb 19–20, 2026 | Planned (10b5-1) | Jack Bendheim (CEO and Director) sold 14,080 shares indirectly between Feb 19 and Feb 20 at about $50.84 ($716K), marked as a 10b5-1 plan trade. Indirect holdings down 38% to 22,600 shares. Filed jointly with 1 other reporting owner. | SEC filing Filed Feb 23, 2026 |
| Feb 13–18, 2026 | Planned (10b5-1) | Jack Bendheim (CEO and Director) sold 14,080 shares indirectly between Feb 13 and Feb 18 at about $51.68 ($728K), marked as a 10b5-1 plan trade. Indirect holdings down 28% to 36,680 shares. Filed jointly with 1 other reporting owner. | SEC filing Filed Feb 18, 2026 |
| Feb 10–11, 2026 | Planned (10b5-1) | Jack Bendheim (CEO and Director) sold 72,198 shares indirectly between Feb 10 and Feb 11 at about $51.77 ($3.7M), marked as a 10b5-1 plan trade. Indirect holdings down 59% to 50,760 shares. Filed jointly with 1 other reporting owner. | SEC filing Filed Feb 11, 2026 |
| Feb 5, 2026 | Planned (10b5-1) | Jack Bendheim (CEO and Director) sold 110,842 shares indirectly at about $48.38 ($5.4M), marked as a 10b5-1 plan trade. Indirect holdings down 47% to 122,958 shares. Filed jointly with 1 other reporting owner. | SEC filing Filed Feb 9, 2026 |
| Feb 3–4, 2026 | Planned (10b5-1) | Jack Bendheim (CEO and Director) sold 13,180 shares indirectly between Feb 3 and Feb 4 at about $41.39 ($545K), marked as a 10b5-1 plan trade. Indirect holdings down 21% to 48,800 shares. Filed jointly with 1 other reporting owner. | SEC filing Filed Feb 5, 2026 |
| Jan 29–30, 2026 | Planned (10b5-1) | Jack Bendheim (CEO and Director) sold 13,465 shares indirectly between Jan 29 and Jan 30 at about $40.11 ($540K), marked as a 10b5-1 plan trade. Indirect holdings down 30% to 31,980 shares. Filed jointly with 1 other reporting owner. | SEC filing Filed Feb 2, 2026 |
| Jan 23, 2026 | Planned (10b5-1) | Jack Bendheim (CEO and Director) sold 1,235 shares indirectly at about $40.55 ($50K), marked as a 10b5-1 plan trade. Indirect holdings down 7% to 15,445 shares. Filed jointly with 1 other reporting owner. | SEC filing Filed Jan 27, 2026 |
| Jan 21–22, 2026 | Planned (10b5-1) | Jack Bendheim (CEO and Director) sold 27,845 shares indirectly between Jan 21 and Jan 22 at about $41.82 ($1.2M), marked as a 10b5-1 plan trade. Indirect holdings down 63% to 16,680 shares. Filed jointly with 1 other reporting owner. | SEC filing Filed Jan 22, 2026 |
| Jan 13–15, 2026 | Planned (10b5-1) | Jack Bendheim (CEO and Director) sold 14,134 shares indirectly between Jan 13 and Jan 15 at about $40.31 ($570K), marked as a 10b5-1 plan trade. Indirect holdings down 24% to 44,525 shares. Filed jointly with 1 other reporting owner. | SEC filing Filed Jan 15, 2026 |
| Jan 9, 2026 | Planned (10b5-1) | Jack Bendheim (CEO and Director) sold 213 shares indirectly at $40.16 ($9K), marked as a 10b5-1 plan trade. Indirect holdings down 1% to 38,659 shares. Filed jointly with 1 other reporting owner. | SEC filing Filed Jan 13, 2026 |
| Jan 7, 2026 | Planned (10b5-1) | Jack Bendheim (CEO and Director) sold 328 shares indirectly at about $40.09 ($13K), marked as a 10b5-1 plan trade. Indirect holdings down 1% to 38,872 shares. Filed jointly with 1 other reporting owner. | SEC filing Filed Jan 8, 2026 |
| Dec 11, 2025 | Planned (10b5-1) | Jack Bendheim (CEO and Director) sold 5,752 shares indirectly at about $40.93 ($235K), marked as a 10b5-1 plan trade. Indirect holdings down 13% to 39,200 shares. Filed jointly with 1 other reporting owner. | SEC filing Filed Dec 15, 2025 |
| Dec 8–9, 2025 | Planned (10b5-1) | Jack Bendheim (CEO and Director) sold 4,808 shares indirectly between Dec 8, 2025 and Dec 9, 2025 at about $40.09 ($193K), marked as a 10b5-1 plan trade. Indirect holdings down 10% to 44,952 shares. Filed jointly with 1 other reporting owner. | SEC filing Filed Dec 10, 2025 |
| Dec 3–4, 2025 | Planned (10b5-1) | Jack Bendheim (CEO and Director) sold 7,040 shares indirectly between Dec 3, 2025 and Dec 4, 2025 at about $41.00 ($289K), marked as a 10b5-1 plan trade. Indirect holdings down 12% to 49,760 shares. Filed jointly with 1 other reporting owner. | SEC filing Filed Dec 4, 2025 |
| Nov 28–Dec 1, 2025 | Planned (10b5-1) | Jack Bendheim (CEO and Director) sold 7,040 shares indirectly between Nov 28, 2025 and Dec 1, 2025 at about $42.10 ($296K), marked as a 10b5-1 plan trade. Indirect holdings down 21% to 26,800 shares. Filed jointly with 1 other reporting owner. | SEC filing Filed Dec 2, 2025 |
| Nov 25–26, 2025 | Planned (10b5-1) | Jack Bendheim (CEO and Director) sold 12,320 shares indirectly between Nov 25, 2025 and Nov 26, 2025 at about $43.97 ($542K), marked as a 10b5-1 plan trade. Indirect holdings down 27% to 33,840 shares. Filed jointly with 1 other reporting owner. | SEC filing Filed Nov 26, 2025 |
| Nov 20, 2025 | Planned (10b5-1) | Jack Bendheim (CEO and Director) sold 3,520 shares indirectly at about $41.76 ($147K), marked as a 10b5-1 plan trade. Indirect holdings down 7% to 46,160 shares. Filed jointly with 1 other reporting owner. | SEC filing Filed Nov 24, 2025 |
| Nov 17–18, 2025 | Planned (10b5-1) | Jack Bendheim (CEO and Director) sold 10,560 shares indirectly between Nov 17, 2025 and Nov 18, 2025 at about $44.19 ($467K), marked as a 10b5-1 plan trade. Indirect holdings down 18% to 49,680 shares. Filed jointly with 1 other reporting owner. | SEC filing Filed Nov 18, 2025 |
| Nov 12–13, 2025 | Planned (10b5-1) | Jack Bendheim (CEO and Director) sold 30,337 shares indirectly between Nov 12, 2025 and Nov 13, 2025 at about $45.01 ($1.4M), marked as a 10b5-1 plan trade. Indirect holdings down 85% to 5,240 shares. Filed jointly with 1 other reporting owner. | SEC filing Filed Nov 13, 2025 |
| Nov 7–10, 2025 | Planned (10b5-1) | Jack Bendheim (CEO and Director) sold 41,823 shares indirectly between Nov 7, 2025 and Nov 10, 2025 at about $45.08 ($1.9M), marked as a 10b5-1 plan trade. Indirect holdings down 67% to 20,577 shares. Filed jointly with 1 other reporting owner. | SEC filing Filed Nov 10, 2025 |
| Nov 4–5, 2025 | Planned (10b5-1) | Jack Bendheim (CEO and Director) sold 7,040 shares indirectly between Nov 4, 2025 and Nov 5, 2025 at about $42.16 ($297K), marked as a 10b5-1 plan trade. Indirect holdings down 10% to 62,400 shares. Filed jointly with 1 other reporting owner. | SEC filing Filed Nov 6, 2025 |
26 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
| Filed | Items | Tag | Source |
|---|---|---|---|
| Nov 4, 2026, 4:31 PM ET 8-K | Earnings released (Item 2.02) Shareholder vote results (Item 5.07) | SEC filing | |
| Nov 3, 2026, 4:15 PM ET 8-K | Other event (Item 8.01) | SEC filing |
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow PAHC in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.